Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting.

Saved in:

Bibliographic Details
Title:	Impact of Obesity and the Metabolic Syndrome on Response to Clopidogrel or Prasugrel and Bleeding Risk in Patients Treated After Coronary Stenting.
Authors:	Pankert, Mathieu^1,2, Quilici, Jacques^1,2, Loundou, Anderson Diendonné³, Verdier, Valentine⁴, Lambert, Marc^1,2, Deharo, Pierre^1,2, Bonnet, Guillaume^1,2, Gaborit, Bénédicte², Morange, Pierre Emmanuel^2,5, Valéro, René^2,6, Dutour, Anne², Bonnet, Jean-Louis^1,2, Alessi, Marie-Christine^2,5, Cuisset, Thomas^1,2 thomas.cuisset@ap-hm.fr
Source:	American Journal of Cardiology. 2014, Vol. 113 Issue 1, p54-59. 6p.
Database:	Academic Search Ultimate

Description
ISSN:	00029149
DOI:	10.1016/j.amjcard.2013.09.011